Stimuli responsive drug delivery application of polymer and silica in biomedicine
Source abstract
Abstract
In the last decade, using polymer and mesoporous silica materials as efficient drug delivery carriers has attracted great attention. Although the development and application of them involves some inevitable barriers, such as chronic toxicities, long-term stability, understanding of the biological fate and physiochemical properties, biodistribution, effect in the biological environment, circulation properties and targeting efficacy in vivo. The construction of stimuli responsive drug carriers using biologically safe materials, followed by hydrophilic modification, bioconjugation, targeting functionalization, and detailed safety analysis in small/large animal models may be the best way to overcome these barriers. Huge progress has been made in stimuli responsive drug delivery systems based on polymer and mesoporous silica materials, mainly including pH-, thermo-, light-, enzyme-, redox-, magnetic field- and ultrasound-responsive drug delivery systems, all of which are highlighted in this review.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications · Hydrogels: synthesis, properties, applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Key Laboratory of Superlight Materials and Surface Technology
Ministry of Education
College of Material Science and Chemical Engineering
Harbin Engineering University
Harbin
State Key Laboratory of Rare Earth Resource Utilization
Changchun Institute of Applied Chemistry
Chinese Academy of Sciences
Changchun
China
SABIC Technology & Innovation Centre
Saudi Basic Industries Corporation (SABIC)
Riyadh 11551
Saudi Arabia
Funding
National Natural Science Foundation of China
References (100+)
Show source-provided references
1. Kramar · Int. J. Pharm. · 2003 · 256 · 4310.1016/S0378-5173(03)00061-9 ↗
2. Stefanadis · J. Clin. Oncol. · 2001 · 19 · 67610.1200/JCO.2001.19.3.676 ↗
3. Gerweck · Cancer Res. · 1999 · 56 · 1194
4. Mu · J. Controlled Release · 2003 · 86 · 3310.1016/S0168-3659(02)00320-6 ↗
5. Fonseca · J. Controlled Release · 2002 · 83 · 27310.1016/S0168-3659(02)00212-2 ↗
6. Danhier · J. Controlled Release · 2009 · 133 · 1110.1016/j.jconrel.2008.09.086 ↗
7. Sahana · J. Pharm. Sci. · 2008 · 97 · 153010.1002/jps.21158 ↗
8. Derakhshandeh · Eur. J. Pharm. Biopharm. · 2007 · 66 · 3410.1016/j.ejpb.2006.09.004 ↗
9. Teixeira · Eur. J. Pharm. Biopharm. · 2005 · 59 · 49110.1016/j.ejpb.2004.09.002 ↗
10. Esmaeili · J. Drug Targeting · 2008 · 16 · 41510.1080/10611860802088630 ↗
11. Labhasetwar · J. Pharm. Sci. · 1998 · 87 · 122910.1021/js980021f ↗
12. Yin · J. Controlled Release · 2007 · 123 · 2710.1016/j.jconrel.2007.06.024 ↗
13. Gomez-Graete · Int. J. Pharm. · 2007 · 331 · 15310.1016/j.ijpharm.2006.11.028 ↗
14. Jin · J. Nanopart. Res. · 2008 · 10 · 104510.1007/s11051-007-9336-1 ↗
15. Sheng · J. Mater. Sci.: Mater. Med. · 2009 · 20 · 1881
16. Sonaje · Pharm. Res. · 2007 · 24 · 89910.1007/s11095-006-9207-y ↗
17. Leroux · J. Controlled Release · 1996 · 39 · 33910.1016/0168-3659(95)00164-6 ↗
18. Gómez-Gaete · J. Controlled Release · 2008 · 128 · 4110.1016/j.jconrel.2008.02.008 ↗
19. Mainardes · J. Pharm. Sci. · 2009 · 98 · 25710.1002/jps.21406 ↗
20. Shenoy · Int. J. Pharm. · 2005 · 293 · 26110.1016/j.ijpharm.2004.12.010 ↗
21. Shah · Pharm. Res. · 2006 · 23 · 263810.1007/s11095-006-9101-7 ↗
22. Damge · J. Controlled Release · 2007 · 117 · 16310.1016/j.jconrel.2006.10.023 ↗
23. Zheng · Acta Biochim. Biophys. Sin. · 2009 · 41 · 57810.1093/abbs/gmp045 ↗
24. Prabu · J. Biomed. Mater. Res., Part A · 2009 · 90A · 112810.1002/jbm.a.32163 ↗
25. José Alonso · Biomed. Pharmacother. · 2004 · 58 · 16810.1016/j.biopha.2004.01.007 ↗
26. Pinto Reis · J. Nanomed. Nanotechnol. · 2006 · 2 · 810.1016/j.nano.2005.12.003 ↗
27. Kim · Biomaterials · 2001 · 22 · 169710.1016/S0142-9612(00)00292-1 ↗
28. Fonseca · J. Controlled Release · 2002 · 83 · 27310.1016/S0168-3659(02)00212-2 ↗
29. Fessi · Int. J. Pharm. · 1989 · 55 · R110.1016/0378-5173(89)90281-0 ↗
30. Zhou · Bioconjugate Chem. · 2012 · 23 · 233510.1021/bc300144e ↗
31. Łukasiewicz · Langmuir · 2015 · 31 · 641510.1021/acs.langmuir.5b01226 ↗
32. Volodkin · Langmuir · 2009 · 25 · 1403710.1021/la9015433 ↗
33. Zhao · Chem. – Eur. J. · 2014 · 20 · 688010.1002/chem.201400348 ↗
34. Qi · Soft Matter · 2011 · 7 · 157110.1039/C0SM00627K ↗
35. Yang · Chem. Commun. · 2011 · 47 · 1216710.1039/c1cc16004d ↗
36. Zhang · Adv. Funct. Mater. · 2015 · 25 · 119310.1002/adfm.201403119 ↗
37. Wang · Adv. Funct. Mater. · 2012 · 22 · 267310.1002/adfm.201102907 ↗
38. Yan · Adv. Mater. · 2012 · 24 · 266310.1002/adma.201200408 ↗
39. Gao · Chem. – Eur. J. · 2012 · 18 · 318510.1002/chem.201103584 ↗
40. Kulkarni · e-Polym. · 2007 · 33 · 1
41. Wang · Carbohydr. Polym. · 2007 · 69 · 33610.1016/j.carbpol.2006.10.014 ↗
42. Dong · Biomacromolecules · 2010 · 11 · 152710.1021/bm100158p ↗
43. Bhattarai · Int. J. Nanomed. · 2006 · 1 · 18110.2147/nano.2006.1.2.181 ↗
44. De Campos · Int. J. Pharm. · 2001 · 224 · 15910.1016/S0378-5173(01)00760-8 ↗
45. Wu · Int. J. Pharm. · 2005 · 295 · 23510.1016/j.ijpharm.2005.01.042 ↗
46. Kaur · Acta Pharm. · 2008 · 58 · 6110.2478/v10007-007-0045-1 ↗
47. Sarmento · Pharm. Res. · 2007 · 24 · 219810.1007/s11095-007-9367-4 ↗
48. Shutava · ACS Nano · 2009 · 3 · 187710.1021/nn900451a ↗
49. Kuntworbe · Acta Trop. · 2013 · 127 · 16510.1016/j.actatropica.2013.04.010 ↗
50. Hamidi · Drug Delivery · 2006 · 13 · 39910.1080/10717540600814402 ↗
51. Li · Biochim. Biophys. Acta · 2009 · 1788 · 225910.1016/j.bbamem.2009.06.022 ↗
52. Wang · ACS Nano · 2013 · 7 · 678210.1021/nn4017179 ↗
53. Xing · Biomaterials · 2012 · 33 · 107910.1016/j.biomaterials.2011.10.039 ↗
54. Idris · Nat. Med. · 2012 · 18 · 158010.1038/nm.2933 ↗
55. Park · Adv. Mater. · 2012 · 24 · 575510.1002/adma.201202433 ↗
56. Li · Adv. Funct. Mater. · 2014 · 24 · 231210.1002/adfm.201303345 ↗
57. Wang · Biomaterials · 2011 · 32 · 614510.1016/j.biomaterials.2011.05.007 ↗
58. Xiong · Anal. Chem. · 2009 · 81 · 868710.1021/ac901960d ↗
59. McBain · Int. J. Nanomed. · 2008 · 3 · 169
60. M. Shinkai and A.Ito, Recent Progress of Biochemical and Biomedical Engineering in Japan II, 2004, vol. 91, p. 19110.1007/b94212 ↗
61. Lee · Nat. Med. · 2006 · 13 · 9510.1038/nm1467 ↗
62. Kircher · Nat. Med. · 2012 · 18 · 82910.1038/nm.2721 ↗
63. Cheng · Biomaterials · 2012 · 33 · 221510.1016/j.biomaterials.2011.11.069 ↗
64. Liong · ACS Nano · 2008 · 2 · 88910.1021/nn800072t ↗
65. Lee · Acc. Chem. Res. · 2011 · 44 · 89310.1021/ar2000259 ↗
66. Slowing · Adv. Funct. Mater. · 2007 · 17 · 122510.1002/adfm.200601191 ↗
67. Liu · J. Mater. Chem. · 2011 · 21 · 717510.1039/c1jm10803d ↗
68. Popat · Nanoscale · 2011 · 3 · 280110.1039/c1nr10224a ↗
69. Ariga · Chem. Soc. Rev. · 2013 · 42 · 632210.1039/c2cs35475f ↗
70. Salinas · Biomater. Sci. · 2013 · 1 · 4010.1039/C2BM00071G ↗
71. Ehlert · Chem. Soc. Rev. · 2013 · 42 · 384710.1039/c3cs35359a ↗
72. Li · Chem. Soc. Rev. · 2012 · 41 · 259010.1039/c1cs15246g ↗
73. Vivero-Escoto · Small · 2010 · 6 · 195210.1002/smll.200901789 ↗
74. Yang · Chem. Soc. Rev. · 2012 · 41 · 367910.1039/c2cs15308d ↗
75. Jessop · Nature · 2005 · 436 · 110210.1038/4361102a ↗
76. Wang · Adv. Mater. · 2010 · 22 · 429310.1002/adma.201001497 ↗
77. Beck · J. Am. Chem. Soc. · 1992 · 114 · 1083410.1021/ja00053a020 ↗
78. Kresge · Nature · 1992 · 359 · 71010.1038/359710a0 ↗
79. Vallet-Regi · Chem. Mater. · 2000 · 13 · 30810.1021/cm0011559 ↗
80. Wu · Chem. Commun. · 2011 · 47 · 997210.1039/c1cc11760b ↗
81. Vallet-Regi · Chem. Soc. Rev. · 2011 · 40 · 59610.1039/C0CS00025F ↗
82. Wei · Materials · 2010 · 3 · 406610.3390/ma3074066 ↗
83. Di Pasqua · Chem. Biodiversity · 2009 · 6 · 134310.1002/cbdv.200900021 ↗
84. He · Biomaterials · 2011 · 32 · 771110.1016/j.biomaterials.2011.06.066 ↗
85. Liu · Biomaterials · 2010 · 31 · 819810.1016/j.biomaterials.2010.07.069 ↗
86. Popovici · J. Pharm. Sci. · 2011 · 100 · 70410.1002/jps.22308 ↗
87. Hocine · Int. J. Pharm. · 2010 · 402 · 22110.1016/j.ijpharm.2010.10.004 ↗
88. Kim · ACS Nano · 2010 · 5 · 36010.1021/nn101740e ↗
89. Slowing · Adv. Drug Delivery Rev. · 2008 · 60 · 12710.1016/j.addr.2008.03.012 ↗
90. Lai · J. Am. Chem. Soc. · 2003 · 125 · 445110.1021/ja028650l ↗
91. Giri · Angew. Chem., Int. Ed. · 2005 · 44 · 503810.1002/anie.200501819 ↗
92. Gruenhagen · Appl. Spectrosc. · 2005 · 59 · 42410.1366/0003702053641513 ↗
93. Zhu · Angew. Chem., Int. Ed. · 2005 · 44 · 508310.1002/anie.200501500 ↗
94. Zhu · Microporous Mesoporous Mater. · 2007 · 103 · 24310.1016/j.micromeso.2007.02.012 ↗
95. Zhao · Chem. Commun. · 2011 · 47 · 945910.1039/c1cc12740c ↗
96. Gao · Mol. Pharmaceutics · 2010 · 7 · 191310.1021/mp100253e ↗
97. Kararli · Biopharm. Drug Dispos. · 1995 · 16 · 35110.1002/bdd.2510160502 ↗
98. Morishita · Drug Discovery Today · 2006 · 11 · 90510.1016/j.drudis.2006.08.005 ↗
99. Sarmento · Biomacromolecules · 2007 · 8 · 305410.1021/bm0703923 ↗
100. Lamprecht · J. Controlled Release · 2004 · 98 · 110.1016/j.jconrel.2004.02.001 ↗